Abstract
The need for mechanical ventilation (MV) has paralleled the growth of the ICU for a ageing population with multiple disease entities, particularly those associated with pulmonary diseases. As the process of ventilation has improved, the etiology of Ventilator-Associated Pneumonia (VAP) has moved from the instrumentation to the colonization of the patient, focusing most recently on the link of normal oral flora as the initial, catalyzing insult in patients at risk for pneumonia through a biofilm in the lumen of the endotrachial tube (ETT).
The ETT, particularly the lumen, is an unrecognised reservoir for biofilms in the evolving discussion of indwelling medical device (IMD)-associated infections; yet it is the perfect environment for such communities to form. The endotrach lumen is protected from systemic therapeutic interventions. The environment is rich with the parameters associated with biofilm development.
Risk factors for ventilator-associated pneumonia and development of ETT luminal biofilms are multi-factorial including: length of hospitalization, surgery, prior antibiotic usage, stress ulcer prophylaxis, host factors such as ARDS, upper aspiratory colonization, and poor oral hygiene. The most significant risk factors, however, appear to be length of mechanical ventilation and prior exposure to antibiotic therapy.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
American Thoracic Society; Infectious Diseases Society of America (2005) Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med 171:388–416
Balaban N, Stoodley P, Fux CA, Wilson S, costerton JW, Dell’Acqua G (2005) Prevention of staphylococcal biofilm-associated infections by quorum sensing inhibitor RIP. Clin Orthop Relat Res 437:48–54
Bauer TT, Torres A, Ferrer R, Heyer CM, Schultze-Werninghaus G, Rasche K (2002) Biofilm formation in endotracheal tubes: association between pneumonia and the persistence of pathogens. Monaldi Arch Chest Dis 57:84–87
Beck-Schimmer B, Madjdpour C, Kneller S, Ziegler U, Pasch T, Wuthrich RP, Ward PA, Schimmer RC (2002) Role of alveolar epithelial ICAM-1 in lipopolysaccharide-induced lung inflammation. Eur Respir J 19:1142–1150
Beck-Schimmer B, Schimmer RC, Pasch T (2004) The airway compartment: chambers of secrets. News Physiol Sci 19:129–132
Bonten MJ, Kollef MH, Hall JB (2004) Risk factors for ventilator-associated pneumonia: from epidemiology to patient management. Clin Infect Dis 38:1141–1149
Cason CL, Tyner T, Saunders S, Broome L (2007) Nurses’ implementation of guidelines for ventilator-associated pneumonia from the Centers for Disease Control and Prevention. Am J Crit Care 16:28–38
Charles PE, Martin L, Etienne M, Croisier D, Piroth L, Lequeu C, Pugin J, Portier H, Chavanet P (2004) Influence of positive end-expiratory pressure (PEEP) on histopathological and bactreriological aspects of pneumonia during low tidal volume mechanical ventilation. Intensive Care Med 30:2263–2270
Chastre J, Fagon YT (2002) Ventilator-associated pneumonia. Am J Respir Crit Care Med 165:867–903
Clutterbrick A et al. (2007) Evaluating antibiotics for use in medicine using a poloxamer biofilm model. Ann. Clin. Micro. and Antimicrobials 6(2)
Cook DJ, Walter SD, Cook RJ (1998) Incidence of and risk factors for ventilator-associated pneumonia in critically ill patients. Ann Intern Med 129:433–440
Davis KA (2006) Ventilator-associated pneumonia: a review. J Intensive Care Med 21:211–226
DeRiso AJ II, Ladowski JS, Dillon TA, Justice JW, Peterson AC (1996) Chlorhexidine gluconate 0.12% oral rinse reduces the incidence of total nosocomial respiratory infection and non-prophylactic systemic antibiotic use in patients undergoing heart surgery. Chest 109:1556–1561
Dhanireddy S, Altemeier WA, Matute-Bello G, O’Mahony DS, Glenny RW, Martin TR, Liles WC (2006) Mechanical ventilation induces inflammation, lung injury, and extra-pulmonary organ dysfunction in experimental pneumonia. Lab Invest 86:790–799
Donlan RM, Costerton JW (2002) Biofilms: survival mechanisms of clinically relevant microorganisms. Clin Microbiol Rev 15:167–193
Dupont H, Mentec H, Sollet JP, Bleichner G (2001) Impact of appropriateness of initial antibiotic therapy on the outcome of ventilator-associated pneumonia. Intensive Care Med 27:355–362
Fagon JY, Rello J (2006) Targeted antibiotic management of ventilator-associated pneumonia. Clin Microbiol Infect 12(Suppl 9):S17–S22
Fourrier F, Cau-Pottier E, Boutigny H, Roussel-Delvallez M, Jourdain M, Chopin C (2000) Effects of dental plaque antiseptic decontamination on bacterial colonization and nosocomial infections in critically ill patients. Intensive Care Med 26:1239–1247
Fux CA, Costerton JW, Stewart PS, Stoodley P (2005) Survival strategies of infectious biofilms. Trends Microbiol 13:34–40
Gilbert P et al. (1998) The use of poloxamer hydrogels for the assessment of biofilm susceptibility towards biocide treatment. J Appl Micro 85:985–990
Grap MJ, Munro CL, Elswick RK Jr, Sessler CN, Ward KR (2004) Duration of action of a single, early, oral application of chlorhexidine on oral microbial flora in mechanically ventilated patients: a pilot study. Heart Lung 33:83–91
Habish M, Reid G (1999) Microbial biofilms: their development and significance for medical device-related infections. J Clin Pharmacol 39:887–898
Hoffken G, Niederman MS (2002) Nosocomial pneumonia: the importance of a de-escalating strategy for antibiotic treatment of pneumonia in the ICU. Chest 122:2183–2196
Houston S, Hougland P, Anderson JJ, LaRocco M, Kennedy V, Gentry LO (2002) Effectiveness of 0.12% chlorhexidine gluconate oral rinse in reducing prevalence of nosocomial pneumonia in patients undergoing heart surgery. Am J Crit Care 11:567–570
Ibrahim EH, Sherman G, Ward S, Fraser VJ, Kollef MH (2000) The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting. Chest 118(1):146–155
Imai Y, Parodo J, Kajikawa O, de Perrot M, Fischer S, Edwards V, Cutz E, Liu M, Deshavjee S, Martin TR, Marshall JC, Ranieri VM, Slutsky AS (2003) Injurious mechanical ventilation and end-rogan epithelial cell apoptosis and organ dysfunction in an experimental model of acute respiratory distress syndrome. JAMA 289:2104–2112
Inglis T, Lim TM, Ng ML, Tang EK, Hui KP (1995) Structural features of tracheal tube biofilm formed during prolonged mechanical ventilation. Chest 106:1049–1052
Isakow W, Kollef MH (2006) Preventing ventilator-associated pneumonia; an evidence-based approach of modifiable risk factors. Semin Respir Crit Care Med 27:5–17
Kollef M (2002) Ventilator-associated pneumonia and ventilator induced lung injury: two peas in a pod. Crit Care Med 30:2391–2392
Kollef MH (2005) What is ventilator-associated pneumonia and why is it important? Chest 50:714–721
Kollef MH (2007) Moving towards real-time antimicrobial management of ventilator-associated pneumonia. Clin Infect Dis 44:388–390. Epub 2007 Jan 3
Kollef MH, Shorr A, Tabak YP, Gupta V, Liu LZ, Johannes RS (2005) Epidemiology and outcomes of healthcare-associated pneumonia: results from a large US database of culture-positive pneumonia. Chest 128:3854–3862
Linden PK, Paterson DL (2006) Parenteral and inhaled colistin for treatment of ventilator-associated pneumonia. Clin Infect Dis 43(Suppl 2):S89–S94
Leid JG, Wilson CJ, Shirtliff ME, Hassett DJ, Parsek MR, Jeffers AK (2005) The Exopolysaccharide alginate protects Pseudomonas aeruginosa biofilm bacteria from IFN-γ-mediated macrophage killing. J Immunol. 171:5886–5894
Leone M, Garcin F, Bouvenot J, Boyadjev I, Visintini P, Albanese J, Martin C (2007) Ventilatorassociated pneumonia: breaking the vicious circle of antibiotic overuse. Crit Care Med 35(2):379–385
Madjdpour C, Oertli B, Ziegler U, Bonvini JM, Pasch T, Beck-Schimmer B (2000) Lipopolysaccharide induces functional ICAM-1 expression in rat alveolar epithelial cells in vitro. Am J Physiol Lung Cell Mol Physiol 278:L572–L579
Madjdpour C, Jewell UR, Sneller S, Ziegler U, Schwendener R, Booy C, Klausli L, Pasch T, Schimmer RC, Beck-Schimmer B (2003) Decreased alveolar oxygen induces lung inflammation. Am J Physiol Lung Cell Mol Physiol 284:L360–L367
Mandell LA, Wunderlink RG, Anzueto A, Bartlett JG, Campbell GD, Dean NG, Dowell SF, File TM Jr, Musher DM, Niederman MS, Torres A, Whitney CG (2007) Infectious disease society of America; American thoracic society guidelines for community-acquired Pneumonia in adults. Clin Infect Dis 44(Suppl 2):S27–S72
Pacheco-Fowler V, Gaonkar T, Wyer PC, Modak S (2004) Antiseptic impregnated endotracheal tubes for the prevention of bacterial colonization. J Hosp Infect 57:170–174
Rello J, Diaz E, Roque M, Valles J (1999) Risk factors for developing pneumonia within 48 hours of intubation. Am J Respir Crit Care Med 159:1742–1746
Rello J, Ollendorf DA, Oster G, Vera-Llonch M, Bellm K, Redman R, Kollef MH (2002) Epidemiology and outcomes of ventilator-associated pneumonia in a large US database. Chest 122:2115–2121
Rello J, Kollef M, Diaz E, Sandiumenge A, delCastillo Y, Corbella X, Zachskom R (2006) Reduced burden of bacterial airway colonization with a novel silver-coated endotracheal tube in a randomized multiple-center feasibility study. Crit Care Med 34:2766–2772
Ruiz M, Torres A, Ewig S, Marcos MA, Alcon A, Lledo R, Asenjo MA, Maldonaldo A (2000) Noninvasive versus invasive microbial investigation in ventilator-associated pneumonia: evaluation of outcome. Am J Respir Crit Care Med 162:119–125
Sanchez-Nieto JM, Torres A, Garcia-Cordoba F, El-Ebiary M, Carrillo A, Ruiz J, Nunez ML, Niederman M (1998) Impact of invasive and noninvasive quantitative culture sampling on outcome of ventilator-associated pneumonia: a pilot study. Am J Respir Crit Care Med 157:371–376. Erratum in Am J Respir Crit Care Med 1998;157:1005
Slutsky AS, Ranieri VM (2000) Mechanical ventilation: lessons from the ARDSNet trial. Respir Res 1:73–77
Tablan OC, Anderson IJ, Besser R, Bridges C, Hajjeh R (2004) Guidelines for preventing healthcareassociated pneumonia, 2003: recommendations of DCD and the Healthcare Infection Control Practices Advisory Committee. MMWR Recomm Rep 53(RR-3):1–36
Zee ED, Schomberh S, Carpenter TC (2006) Hypoxia upregulates lung microvascular neurokinin-1 receptor expression. Am J Physiol Lung Cell Mol Physiol 291:L102–L110
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2008 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Thomas, J.G., Corum, L., Miller, K. (2008). Biofilms and Ventilation. In: Shirtliff, M., Leid, J.G. (eds) The Role of Biofilms in Device-Related Infections. Springer Series on Biofilms, vol 3. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-68119-9_4
Download citation
DOI: https://doi.org/10.1007/978-3-540-68119-9_4
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-68113-7
Online ISBN: 978-3-540-68119-9
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)